The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis
Abstract
The prevalence, associations, and natural history of pain in multiple sclerosis (MS) are poorly understood. The objective of this work was to study the prevalence of pain syndromes in MS both cross-sectionally, and longitudinally during the MS disease course. We systematically identified prospective studies detailing pain prevalence in definite MS. We used pooled prevalence estimates, explored heterogeneity using meta-regression, and analysed prevalence during the disease course using both estimates at disease milestones and longitudinal studies. Twenty-eight articles (7101 subjects) describing overall pain, or pain syndromes, met inclusion criteria. Pooled overall pain prevalence (17 studies, 5319 subjects) was 63% (95% confidence interval [CI] 55-70%). Marked heterogeneity in this estimate was not significantly explained by selected study design variables (use of outpatient sample, timeframe prior to study over which pain was assessed) or sample demographic variables (mean Expanded Disability Status Scale, mean disease duration, proportion of female sex, and proportion with progressive MS). We quantified prevalence of headache (43%; 95% CI 33-52%), neuropathic extremity pain (26%; 95% CI 7-53%), back pain (20%; 95% CI 13-28%), painful spasms (15%; 95% CI 8.5-23%), Lhermitte sign (16%; 95% CI 10-25%), and trigeminal neuralgia (3.8%; 95% CI 2-6%) in included studies. Prevalence of pain at MS disease milestones (prior to onset, at onset, and at relapse) and during longitudinal follow-up was poorly described. Pain is common in MS, as are specific pain syndromes. The clinical associations and natural history of pain in MS require clarification. Future study could be enhanced by standardised study design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reason for this was the substantial heterogeneity in the reported prevalence of such subtypes (Foley et al. 2013).”
From The Prevalence of Neuropathic Pain in Multiple Sclerosis—A Systematic Review and Meta‐Analysis Using the NeuPSIG Algorithm (2026) · cites this paper as Foley et al. 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Diagnostic criteria for multiple sclerosis
Poser, C. M., & Brinar, V. V. (2001) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(00)00125-6 · Cited by 1,283
Pregabalin for acute and chronic pain in adults
Moore, R. A., Straube, S., Wiffen, P. J., Derry, S., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub2 · Cited by 762
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
Cited by
Neuropathic pain: Definition, assessment and epidemiology
Bouhassira, D. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2018.09.016 · Cited by 398
Challenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
Feinstein, A., Freeman, J., & Lo, A. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70231-5 · Cited by 281
Moisset, X., Ouchchane, L., Guy, N., Bayle, D. J., Dallel, R., & Clavelou, P. (2013) · Pain · doi:10.1016/j.pain.2013.07.050 · Cited by 86
Meditation as an adjunct to the management of multiple sclerosis.
Levin, A. B., Hadgkiss, E. J., Weiland, T. J., & Jelinek, G. A. (2014) · Neurology Research International · doi:10.1155/2014/704691 · Cited by 77
Non-pharmacological interventions for chronic pain in multiple sclerosis
Amatya, B., Young, J., & Khan, F. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012622.pub2 · Cited by 78
Vitkova, M., Gdovinova, Z., Rosenberger, J., Szilasiova, J., Nagyová, I., Mikula, P., Krokavcova, M., Groothoff, J. W., & van Dijk, J. P. (2014) · Disability and health journal · doi:10.1016/j.dhjo.2014.05.004 · Cited by 63
Valentine, T. R., Alschuler, K. N., Ehde, D. M., & Kratz, A. L. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211023352 · Cited by 55
Cognitive Behavioral Therapy for the Management of Multiple Sclerosis–Related Pain
Gromisch, E. S., Kerns, R. D., Czlapinski, R., Beenken, B., Otis, J., Lo, A. C., & Beauvais, J. (2020) · International Journal of MS Care · doi:10.7224/1537-2073.2018-023 · Cited by 34
Mack, D. S., Hunnicutt, J., Jesdale, B., & Lapane, K. (2018) · Journal of Pain Research · doi:10.2147/jpr.s158128 · Cited by 31
Rodrigues, P., da Silva, B., & Trevisan, G. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105401 · Cited by 31
Shkodina, A. D., Bardhan, M., Chopra, H., Anyagwa, O. E., Pinchuk, V. A., Hryn, K. V., Kryvchun, A. M., Boiko, D. I., Suresh, V., Verma, A., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01072-5 · Cited by 31
Simpson, R., Simpson, S., Wasilewski, M., Mercer, S., & Lawrence, M. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2021.1964622 · Cited by 30
Association Between Pain and Mindfulness in Multiple Sclerosis
Senders, A., Borgatti, A., Hanes, D., & Shinto, L. (2018) · International Journal of MS Care · doi:10.7224/1537-2073.2016-076 · Cited by 28
Foley, P., Kong, Y., Dirvanskiene, R., valdes-Hernandez, M., Bastiani, M., Murnane, J., Sellar, R., Roberts, N., Pernet, C., Weir, C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac124 · Cited by 11
Self-citationRisk factors of neuropathic pain in multiple sclerosis: a retrospective case-cohort study
Ouyang, H., Li, X., Xu, H., Zhan, Y., Zheng, Z., Chen, G., Lou, Z., Chen, H., Zhang, J., Mao, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1309583 · Cited by 9
“According to previous studies, neuropathic pain may arise from lesions within the somatosensory nervous system(7, 14) which was found to be closely related to the pathophysiology of MS(4).”
BackgroundCentral Pain in Patients with Multiple sclerosis
S, F., I, W., P, V., & J, M. (2017) · Journal of Multiple Sclerosis · doi:10.4172/2376-0389.1000208 · Cited by 8
“The most common type of central pain in multiple sclerosis is non-paroxysmal, continuous extremity pain (dysaesthesias or ongoing pain) of the arms, legs or trunk occurring in 14-29% of multiple sclerosis patients [4,6-11].”
BackgroundResultInfluentialJungersen, R. C., Baccaro, V. K., Hvid, L. G., Dalgas, U., & Hoegh, M. (2026) · European Journal of Pain · doi:10.1002/ejp.70375 · Cited by 1
“Pain is a common problem in pwMS, estimated to affect up to 86%, and it significantly reduces quality of life (Foley et al. 2013).”
Influential
Metadata
- Authors
- Foley, P. L., Vesterinen, H. M., Laird, B. J., Sena, E. S., Colvin, L. A., Chandran, S., MacLeod, M. R., & Fallon, M. T.
- Venue
- Pain
- Published
- 2013-05
- Volume
- 154
- Issue
- 5
- Pages
- 632-642
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2168285239
- Cited by
- 310
- References
- 52
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.